Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking Cessation

NCT00464165 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
789
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi